Low tumor interleukin-1β expression predicts a limited effect of adjuvant platinum-based chemotherapy for patients with completely resected lung adenocarcinoma: An identification and validation study

Adjuvant platinum-based chemotherapy for completely resected non-small cell lung cancer is associated with modest improvement in survival; nevertheless, no validated biomarker exists for predicting the benefit or harm of adjuvant platinum-based chemotherapy. We simultaneously measured 27 cytokines i...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Pulmonology 2024-04
Hauptverfasser:	Safi, S., Krzykalla, J., Hoffmann, H., Benner, A., Bischoff, H., Eichhorn, M., Kriegsmann, M., Poschke, I., Stögbauer, F., Umansky, L., Mogler, C., Weichert, W., Winter, H., Beckhove, P., Muley, T.
Format:	Artikel
Sprache:	eng
Schlagworte:	Biomarkers Cytokines IL-1β Lung neoplasms Tumor microenvironment
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!